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Abstract
Introduction: Proteinuria in burn patients is common, and may be associated with acute kidney injury (AKI) and
adverse outcomes. We evaluated the incidences, outcomes, characteristics and determinants of proteinuria and its
influence on AKI and outcomes in burn patients.
Methods: This retrospective study was carried out in a hospital’s burn department. The study population consisted
of patients with burn injuries admitted during a five-year period. Positive urine dipstick readings were defined as
mild (± or 1+) or heavy (≥ 2+) proteinuria, and AKI was diagnosed and staged according to the Risk, Injury, Failure,
Loss, End Stage (RIFLE) classification system. Patient characteristics, management and outcomes were evaluated for
associations with proteinuria using nonparametric tests, chi-square (c2) tests and binary logistic regression.
Results: Of the patients admitted to the burn unit during the study period (n = 2,497), 865 (34.64%) were classified
as having proteinuria. In the patients whose total burn surface areas (TBSA) were > 30% (n = 396), 271 patients
(68.43%) had proteinuria and 152 of these patients (56.09%) met AKI criteria. No patients without proteinuria
developed AKI. Intensive care unit (ICU) mortality rates were 0.8%, 16.67% and 30.77% (P < 0.001) in the groups
with no, mild and heavy proteinuria, respectively. Logistic regression analysis identified proteinuria (OR 4.48; 95% CI,
2.824 to 7.108; P < 0.001) and sequential organ failure assessment (OR 1.383; 95% CI, 1.267 to 1.509; P < 0.001) as
risk factors for AKI.
Conclusions: We observed a high prevalence of proteinuria in patients with severe burns (> 30% TBSA). Severely
burned patients with proteinuria had a high risk of developing AKI and a poor prognosis for survival. This suggests
that proteinuria should be used for identifying burn patients at risk of developing AKI.
Keywords: Severe burn, Proteinuria, Acute kidney injury, Risk factors, Mortality
Introduction
Acute kidney injury (AKI) is increasingly common and is
associated with adverse short- and long-term outcomes in
various clinical settings [1], including patients with severe
burns [2]. In the acute phase, as kidney function declines,
AKI is associated with excess mortality [3,4], maximum
Sequential Organ Failure Assessment (SOFA) and
extended intensive care unit (ICU) stays [2,5,6]. Although
kidney function recovers for most burn patients survivors
[7-10], some survivors have persistent loss of kidney
function and require long-term dialysis [11]. The key strat-
egy for prevention of AKI is to identify those at highest
risk so that prophylactic measures can be administered.
As defined by the RIFLE (Risk, Injury, Failure, Loss, End
Stage) classification system, the diagnosis of AKI is cur-
rently based on changes in the serum creatinine (sCr) or
urine output [12,13]. However, these parameters often lag
behind acute changes in renal function and, therefore,
underestimate the degree of renal dysfunction in acute
care settings [14]. Recent improvements in understanding
AKI have resulted in the implementation of proteinuria
[13,15-17] and some novel biomarkers [18-20] as means of
more accurately assessing for AKI.
Proteinuria is an indicator of both glomerular and renal
endothelial injury in chronic disease [21,22], acute illness
* Correspondence: augustus100@sina.com
† Contributed equally
1Institute of Burn Research, Southwest Hospital, State Key Laboratory of
Trauma, Burns and Combined Injury, Chongqing Key Lab for Disease
Proteomics, Third Military Medical University, Chongqing 400038, PR China
Full list of author information is available at the end of the article
Hu et al. Critical Care 2012, 16:R172
http://ccforum.com/content/16/5/R172
© 2012 Hu et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
or is due to surgery [23-26]. Glomerular proteinuria is a
feature of chronic kidney disease (CKD) and intrinsic
renal disease, whereas tubular proteinuria occurs more fre-
quently in AKI. Dipstick urinalysis is a cheap and conveni-
ent means of diagnosing proteinuria, and it is a routine
test for in-patients in our burn center (the Burn Depart-
ment of Southwest Hospital). Proteinuria is commonly
observed in patients with severe burns [27,28], but the
usefulness of proteinuria for predicting the risk of AKI
and prognosis has not been documented for burn patients.
In this study, we examined associations between protei-
nuria and adverse clinical outcomes, including mortality
and AKI incidence in burn patients. We hypothesized that
burn patients with proteinuria would be at higher risk of
AKI and adverse outcomes than patients without
proteinuria.
Materials and methods
This retrospective study was conducted over a five-year
period (October 2006 to September 2010) in a 200-bed
specialized burn department. All patients with burn
injuries admitted to the Burn Department of Southwest
Hospital were included in the study. This study was
approved by the Human Subjects Review Board of The
Third Military Medical University, and did not require
informed consent because it was a study of routinely
collected clinical data. All relevant information was pro-
vided following the STROBE (STrengthening the
Reporting of OBservational studies in Epidemiology)
Guideline.
Exclusion criteria for the study were: age < 18 years or
> 75 years; non-burn diagnosis (reconstructive surgery);
non-survivable burns (decision for comfort care on admis-
sion); pregnancy; admission for less than 72 h; previous
dialysis; previous abnormal renal function with sCr > 133
μmol/L; or diagnosed with diabetes or hypertension.
Patient resuscitation in the first 48 h was based on the
Third Military Medical University formula [29] (see Addi-
tional file 1). Thereafter, maintenance crystalloid infusion
rates were calculated using standard formulas for insensi-
ble wound fluid losses. Urine volumes > 0.5 ml/Kg· h-1 in
the first 48 h post injury were considered to be indicative
of effective resuscitation. Enteral or intravenous nutrition
was provided after the first 48 h post-injury for patients
with total burn surface areas (TBSA) > 50%, and prophy-
lactic antibiotics were used for patients with TBSA > 30%.
Demographic and clinical data were recorded for each
patient, including proteinuria; sCr; TBSA and depth;
comorbidities; escharotomies; inhalation, chemical, or
electrical injuries; mechanical ventilation; continuous renal
replacement therapy (CRRT); abdominal compartment
syndrome (ACS); nephrotoxic drugs (vancomycin, ampho-
tericin B, polymyxin E, aminoglycosides); vasopressors
(dopamine, epinephrine, norepinephrine); administration
of colloidal solutions for resuscitation; urine volume in the
first 48 h post injury; ICU length of stay; and mortality.
Intra-abdominal pressure (IAP) was measured using once
daily urinary bladder pressure measurements, and ACS
was defined as a sustained IAP > 20 mm Hg that was asso-
ciated with development of organ dysfunction/failure [30].
Proteinuria was determined with urine dipsticks using an
automated urine analyzer (H800, Dirui, Changchun,
China), and defined as normal (negative), mild (± or 1+,
approximately > 5 to 20 mg/dL), or heavy (≥ 2+, approxi-
mately ≥ 100 mg/dL). The maximal level of proteinuria
prior to the first diagnosis of AKI was recorded in AKI
patients and the maximum level at any time in non-AKI
patients. Urine protein results were recorded by the
laboratory examiner, and the urine analyzer was calibrated
by the factory engineer every two weeks to ensure accu-
racy and precision.
Baseline sCr values were measured within three months
prior to admission. For the patients without a sCr test
within three months, the first sCr value after admission
was adopted as the baseline sCr values if the first sCr
value was normal (< 106 μM for male, and < 88 μM for
female). If the first sCr value was abnormal, patients were
assigned to a baseline eGFR of 75 ml/min/1.73 m2, and
the Modification of Diet in Renal Disease (MDRD) equa-
tion was applied [12,31]. The RIFLE class was determined
according to the worst degree of either sCr or urine out-
put criteria [12]. Systemic inflammatory response syn-
drome (SIRS) and sepsis were diagnosed according to
criteria defined by the American College of Chest Physi-
cians and the Society of Critical Care Medicine [32]. For
the diagnosis of multiple organ dysfunction or failure,
Sequential Organ Failure Assessment (SOFA) Scores were
computed daily and the maximum was used for this study
[33].
Statistical analysis
Continuous variables were expressed as medians and
quartile ranges. Dichotomous and categorical variables
were expressed as proportions and compared using non-
parametric and chi-square (c2) tests. Comparisons of
location parameters for continuous data were analyzed
with Mann-Whitney U and Kruskal-Wallis H tests. Risk
factors were assessed using a binary logistic regression
with proteinuria, AKI and ICU mortality as the depen-
dent outcome variables. In all comparisons, a P-value of
< 0.05 was considered statistically significant. Statistical
analyses were performed with the software program IBM
SPSS STATISTIC, version 19 (SPSS Inc, Chicago, IL,
USA).
Results
A total of 3,224 patients were admitted to the Burn
Department during the study period, and 2,497 patients
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met the study’s inclusion criteria (Figure 1). Patients
were excluded on the basis of non-burn diagnoses (n =
346); age < 18 years or > 75 years (n = 237); abnormal
renal function preoperatively (defined as sCr > 133
μmol/L) or previous dialysis (n = 12); patients who
stayed less than 72 hours after admission (n = 72);
patients who elected comfort care upon admission (n =
32); and pregnancy (n = 28).
All patients had their first measurement of proteinuria
and sCr around 2 h after admission. Maximum proteinuria
values of the remaining 2,497 patients and maximum sCr
values of the 396 patients, whose TBSA > 30%, were
recorded, in which maximum proteinuria was defined as
the maximum value before AKI incidence for patients
with AKI. Patient proteinuria and TBSA values were sum-
marized (Table 1). In the remaining 2,497 patients, 865
(34.64%) developed proteinuria, and the patients with lar-
ger TBSA were more likely to have proteinuria (P < 0.001).
The difference between the first and maximum protei-
nuria has been summarized in Figure 2. Of the patients
with TBSA > 30% (n = 396), 271 patients had proteinuria,
in which 211 had proteinuria at their first measurement.
A total of 151 patients developed AKI, 43 of which had
AKI on admission. It should be specially noted that none
of the patients without proteinuria had AKI, which
means that the continued absence of proteinuria excludes
the development of AKI.
Patient categories were compared based on proteinuria
(Table 2). Of the patients with TBSA > 30% (n = 396), 180
(45.45%) had mild and 91 (22.98%) had heavy proteinuria.
Of the patients with proteinuria (n = 271), 151 (55.72%)
had AKI, with RIFLE classifications of: Risk (n = 83;
Figure 1 Study flow. The details of recruitment and inclusion, and the procedures of data collection.
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54.97%); Injury (n = 52; 34.44%); and Failure (n = 16;
10.60%). Non-parametric tests (univariate analysis) showed
significant differences among the groups for: age, TBSA,
ACS, escharotomy, comorbidities, nephrotoxic drugs,
inhalation injury, urine output at the shock stage, vaso-
pressor in first 48 h, sepsis during the ICU stay, positive
blood culture, maximum SOFA and RIFLE (P < 0.05).
Patients with proteinuria were prone to having CRRT (P =
0.013), longer mechanical ventilation duration (P < 0.001),
longer ICU stays (P < 0.001), and higher mortality rates
(0.8%, 16.67% and 30.77% for none, mild and heavy protei-
nuria) (P < 0.001).
The characteristics and outcomes of patients with pro-
teinuria according to AKI were summarized (Table 3).
Among the 396 patients with TBSA > 30%, 357 had base-
line sCr values, whereas the remaining 41 used eGFR
derived values. When diagnosing the AKI, 102 achieved
RIFLE maximum by sCr criteria, 19 by urine criteria and
31 by both criteria. The patients with AKI had higher
TBSA, ACS, escharotomy, proteinuria, sepsis during ICU
stay and maximum SOFA values compared to the patients
without AKI (P < 0.05). Patients with AKI were prone to
have CRRT (P = 0.002), longer mechanical ventilation
durations (P < 0.001), and extended ICU stays (P < 0.001).
Mortality rates of patients with and without AKI were
12.50% and 28.48% (P = 0.001), respectively.
Logistic regression analysis identified TBSA (OR 1.038;
95% CI, 1.022 to 1.054; P < 0.001), sepsis (OR 1.052;
95% CI, 1.539 to 5.331; P = 0.001), and age (OR 1.026;
95% CI, 1.007 to 1.046; P = 0.006) as independent risk
factors for proteinuria (Table 4); SOFA (OR 1.383; 95%
CI, 1.267 to 1.509; P <0.001) and proteinuria (OR 4.480;
95% CI, 2.824 to 7.108; P < 0.001) as independent risk
factors for AKI (Table 5); age (OR 1.085; 95% CI, 1.048
to 1.123; P < 0.001), TBSA (OR 1.053; 95% CI, 1.032 to
1.075; P < 0.001), proteinuria (OR 1.932; 95% CI, 1.000
to 3.734; P = 0.050), associated injury (OR 2.446; 95%
CI, 3.986 to 33.440; P < 0.001) and RIFLE (OR 2.289;
95% CI, 1.577 to 3.322; P < 0.001) as independent risk
factors for ICU mortality (Table 6).
Discussion
In this hospital-based study, we found that proteinuria
was common (68.26%) in severe burn patients (> 30%
TBSA), and proteinuria should be used to identify severe
burn patients at risk of AKI, as well as for prognosis and
identification of burn patients needing intensive care.
Acute kidney injury is characterized as a rapid loss of
kidney function which clinically manifests as an abrupt
and sustained rise in urea and creatinine. Life threatening
consequences of AKI include volume overload, metabolic
acidosis, hyperkalaemia and effects on other organ systems
[34]. AKI is associated with increased morbidity, mortality
and hospitalization costs [19]. So it is significantly mean-
ingful to identify the patients at risk of AKI and take
appropriate treatments. However, decreased creatinine
production and hemodilution will significantly blunt
increases in creatinine that could be indices of AKI in
Figure 2 Flow chart of patients’ progress. The details of acute kidney injury and proteinuria progression.
Table 1 Comparison of TBSA with proteinuria (n = 2,497)






≤ 10 973 324 24.98
11 to 30 533 270 33.62
31 to 50 99 110 52.63
51 to 70 16 67 80.72
> 70 11 94 89.52
TBSA, total burn surface area
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burn patients. Furthermore, some patients with protei-
nuria may die before they are diagnosed with AKI.
It is established that the risks of death and AKI progres-
sion, or end-stage renal disease associated with AKI, vary
with levels of proteinuria [10,35]. Proteinuria in the
absence of AKI is common in severe burn patients and
may indicate sub-clinical AKI. However, current guidelines
for the classification and staging of AKI do not explicitly
consider concomitant proteinuria [13] and, therefore, may
not identify individuals at risk for developing AKI when
sCr is normal but proteinuria exists.
Dipstick urinalysis was used for measurement of protei-
nuria in our study. Dipstick urinalysis has less favorable
diagnostic properties for the assessment of proteinuria
than quantitative measurements of proteinuria, such as
24-hour urine collection tests. However, it is the most
common test and is much cheaper, readily available, feasi-
ble and practical, compared with automated measures.
The validity of proteinuria readings was established with a
significant correlation between dipstick and 24-hour urine
collection testing using bivariate correlation analysis (n =
40, P <0.001; data not shown). Although our findings do
not address whether dipstick urinalysis or urine sample
measurement of albumin is preferable for risk assessment
in clinical practice, they do suggest that for burn patients,
testing of proteinuria using simple dipstick methodology is
prognostic for AKI outcomes.
The majority of proteinuria in AKI is due to tubular
injury that prevents protein absorption, as well as release
of tubular proteins into the ultrafiltrate. However, kidney








Age (years) 38 (16.00) 42 (16.75) 41 (15.00) 0.050
Gender (% of males) 72.80 83.89 86.81 0.150
TBSA (%) 38 (15.50) 54.4 (35.00) 70 (41.00) < 0.001
dTBSA (%) 35 (13.50) 48 (33.00) 60 (39.00) < 0.001
Escharotomy (%) 3 (15.50) 9 (27.75) 24 (38.00) < 0.001
Electrical injury (%) 7.20 7.22 10.99 0.511
Chemical injury (%) 24.00 17.88 10.99 0.049
Inhalation injury (%) 25.60 46.67 48.35 < 0.001
Comorbidities (%) 1.60 9.44 7.69 0.042
ACS (%) 3.20 17.78 25.78 < 0.001
Vasopressor in first 48 h (%) 0.80 6.67 7.69 0.030
Artificial colloid (%) 38.46 53.72 53.85 0.341
Albumin (%) 57.69 34.71 32.05 0.540
Urine output at shock stage (%, ≥ 0.5 ml/Kg·h-1) 97.60 75.00 64.84 < 0.001
Nephrotoxic drugs (%) 23.08 51.24 55.13 0.015
Length of mechanical ventilation (days) 0 (0.00) 0 (2.00) 1 (6.00) > 0.001
Sepsis during ICU stay (%) 15.20 46.11 67.03 < 0.001
Positive blood culture (%) 54.51 58.37 87.12 < 0.001
Gram-positive bacteria (%) 9.68 51.61 38.71 < 0.001
Gram-negative bacteria (%) 23.53 50.00 26.47 < 0.001
Positive culture, others (%) 0.00 51.56 48.44 < 0.001
Maximum RIFLE < 0.001
No AKI (%, n = 245) 51.02 36.73 12.24 < 0.001
Risk (%, n = 83) 0.00 61.45 38.55 < 0.001
Injury (%, n = 52) 0.00 61.54 38.46 < 0.001
Failure (%, n = 16) 0.00 43.75 56.25 < 0.001
Maximum SOFA 0 (0.00) 4 (7.00) 6 (8.00) < 0.001
CRRT during ICU stay (%) 0.00 5.00 7.69 < 0.001
Length of CRRT treatment (days) 0 (0.00) 0 (0.00) 0 (2.00) 0.013
ICU length of stay (days) 0 (0.00) 2 (30.00) 4 (49.00) < 0.001
ICU mortality (%) 0.8 16.67 30.77 < 0.001
ACS, abdominal compartment syndrome; CRRT, continuous renal replacement therapy; dTBSA, total surface area of deep second degree or third degree burn;
ICU, intensive care unit; RIFLE, Risk, Injury, Failure, Loss, End Stage classification; SOFA, sequential organ failure assessment; TBSA, total burn surface area.
Continuous variables, median (quartile range); categorical variables, (%).
Variables coding: Maximum RIFLE 1: No-AKI, 2: Risk, 3: Injury, 4: Failure + loss + end stage
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biopsies of eight patients with persistent AKI/proteinuria
documented co-existent glomerular disease (data not
shown). This suggests that the role of glomerular injury
in AKI, particularly where there is sepsis and inflamma-
tion, is incompletely understood and may be of greater
significance than currently recognized.
Intrinsic AKI is often multifactorial. Renal ischemia is
probably less important in the acute phase of burn injury
than originally presumed [36]. Instead, inflammation and
sepsis probably play important roles [37-39]. An impor-
tant difference between burn and other types of ICU
patients may be the intensity and duration of the inflam-
matory response, which may persist longer than in other
trauma patients [40]. Sepsis in severe burn patients, often
accompanied by multi-organ failure (represented by
SOFA), was identified as a risk factor for proteinuria by
our regression analysis (Table 4), as well as for AKI
(Table 5). Sepsis-related inflammatory and thrombogenic
factors are considered risk factors for direct renal par-
enchymal damage [41,42].
This observational study has limitations. First, the burn
patients were primarily male, and misclassifications of
baseline kidney function could have occurred because of
deficiencies in previous examinations. Second, misclassi-
fications of proteinuria might occur because of known
variability of urine dipstick measurements, even though
Table 3 Characteristics and outcomes of patients with proteinuria according to AKI (n = 271)
Proteinuria without AKI
(n = 120)
Proteinuria accompanied with AKI
(n = 151)
P-value
Age (years) 41 (17.75) 41 (16.00) 0.685
Gender (% of male) 72.80 79.17 0.200
TBSA (%) 47.5 (34.75) 70 (35.00) < 0.001
dTBSA (%) 42 (25.75) 58 (37.00) < 0.001
Escharotomy (%) 7 (28.50) 18 (38.00) < 0.001
Electrical injury (%) 8.33 8.61 0.936
Chemical injury (%) 19.17 12.58 0.138
Inhalation injury (%) 43.33 50.33 0.226
Comorbidities (%) 10.00 8.95 0.630
ACS (%) 14.17 25.17 0.033
Vasopressor in first 48 h (%) 5.00 8.61 0.249
Artificial colloid (%) 56.14 52.82 0.672
Albumin (%) 42.11 30.28 0.111
Proteinuria at heavy stage (%) 22.71 42.14 0.001
Urine output in shock stage (%, ≥ 0.5 ml/Kg·h-1) 77.19 54.93 < 0.001
Nephrotoxic drugs (%) 45.61 55.63 0.202
Length of mechanical ventilation (days) 0 (3.00) 1 (6.00) < 0.001
Sepsis during ICU stay (%) 41.67 62.25 0.001
Positive blood culture (%) 71.28 74.35 0.102
Maximum SOFA 0 (5.00) 7 (9.00) < 0.001
CRRT during ICU stay (%) 8.30 9.93 0.002
Length of CRRT treatment (days) 0 (0.00) 0 (2.00) 0.002
ICU length of stay (days) 0 (24.75) 11 (45.00) < 0.001
ICU mortality (%) 12.50 28.48 0.001
ACS, abdominal compartment syndrome; AKI, acute kidney injury; CRRT, continuous renal replacement therapy; ICU, intense care unit; SOFA, sequential organ
failure assessment; TBSA, total burn surface area; tTBSA, total surface area of third degree burn. Continuous variables, median (quartile range); categorical
variables, (%)
Table 4 Logistic regression model: risk factors for proteinuria (n = 396)
Covariates associated with proteinuria Coefficient Odds ratio 95% Confidence interval P-value
TBSA (%) 0.037 1.038 1.022 to 1.054 < 0.001
Sepsis during ICU stay 1.052 2.864 1.539 to 5.331 0.001
Age 0.026 1.026 1.007 to 1.046 0.006
ICU, intense care unit; TBSA, total burn surface area
Covariates selected: Age, TBSA, ACS, inhalation injury, vasopressor in the first 48 h, comorbidities, albumin, sepsis during ICU stay
Variables coding: Proteinuria 1: (-), 2: ≥ (±)
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we established a significant correlation between dipstick
measurements and the 24 h urine test. Finally, we could
not exclude the possibility of residual confounding due to
burn severity, blood pressure, large amounts of fluid
resuscitation and the administration of drugs. Further-
more, the unusual composition of urinary proteins
(decreased filtered load of albumin, increased load of
acute phase reactants or alterations in protein processing
in renal tubules) compromises the use of urinary protein
measurements for detecting kidney injury in burn
patients [27]. Nonetheless, our results were consistent for
several clinically relevant outcomes, including AKI,
CRRT and mechanical ventilation duration, ICU length
of stay and mortality. These findings are important
because current guidelines for the classification and sta-
ging of AKI are based on sCr and urine volume, without
explicit consideration of the severity of concomitant or
independently existing proteinuria, especially in severe
burn patients.
Conclusions
In conclusion, proteinuria was common (68.26%) in
severe burn patients (> 30% TBSA), and proteinuria was
clearly associated with increased risk for developing
AKI, long-term ICU stays and mortality. Age, TBSA and
sepsis were considered as independent risk factors for
proteinuria in the post-burn period, and maximum
SOFA and proteinuria as risk factors for AKI. Age,
TBSA, proteinuria, comorbidities and RIFLE were
regarded as risk factors for ICU mortality. These find-
ings demonstrate that proteinuria should be used to
identify severe burn patients at risk of developing AKI
and unfavorable clinical outcomes.
Key messages
• Almost two-thirds of severe burn patients (> 30%
TBSA) develop new onset proteinuria.
• Proteinuria is associated with increased risk for
AKI, ICU length of stay and mortality.
• Age, TBSA and sepsis are considered as independent
risk factors for proteinuria in the post-burn period.
• Maximum SOFA and proteinuria are regarded as
risk factors for AKI.
Additional material
Additional file 1: The Third Military Medical University formula. A
description of the Third Military Medical University formula for patient
resuscitation.
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